Related Experiment Videos
Progesterone has no effect on serum thyroxine-binding globulin concentration in men
The Journal of Clinical Endocrinology and Metabolism
|November 1, 1985
Summary
Progesterone, specifically medroxyprogesterone acetate, does not affect thyroid hormone levels in men. Studies show no significant changes in thyroxine-binding globulin (TBG) or total T4 concentrations after progesterone administration.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Pharmacology
Background:
- Thyroid hormones are crucial for metabolic regulation.
- Thyroxine-binding globulin (TBG) influences thyroid hormone availability.
- Progestational agents are used in various medical conditions.
Purpose of the Study:
- To investigate the impact of progesterone on circulating TBG and T4 levels in men.
- To determine if medroxyprogesterone acetate affects thyroid hormone binding and concentration.
Main Methods:
- Radioimmunoassay (RIA) measurements of plasma TBG and T4.
- Weekly intramuscular administration of 500 mg medroxyprogesterone acetate.
- Measurements taken before and after short-term (7-29 days) and long-term (381-415 days) treatment.
Main Results:
- No significant change in mean plasma TBG concentration was observed after short-term or long-term medroxyprogesterone treatment.
- Mean plasma T4 concentration remained unaltered by both acute and chronic medroxyprogesterone therapy.
- Individual patient data showed no consistent effect of progesterone on TBG or T4 levels.
Conclusions:
- Progestational agents, when administered alone, do not alter circulating TBG concentrations in men.
- Progesterone does not modify total T4 concentrations in men.
- These findings suggest that progesterone's effects on thyroid hormone transport are minimal in the male population.